{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:40:06Z","timestamp":1758937206552,"version":"3.44.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012264","name":"NIH","doi-asserted-by":"publisher","award":["P30 CA77598)"],"award-info":[{"award-number":["P30 CA77598)"]}],"id":[{"id":"10.13039\/501100012264","id-type":"DOI","asserted-by":"publisher"}]},{"name":"American Cancer Society, F"},{"name":"rederick A. DeLuca Foundation, M"},{"name":"entored Research Scholar Grant","award":["MRSG-16-195-01-DDC"],"award-info":[{"award-number":["MRSG-16-195-01-DDC"]}]},{"name":"Clinical and Translational Science Institute at the University of Minnesota KL2 Career Development"},{"name":"University of Minnesota Department of Medicine Women\u2019s Early Research Career Award"},{"name":"division of Hematology, Oncology, and Transplantation, Department of Medicine"},{"name":"University of Minnesota Foundation donors"},{"name":"Hematology T32 Research Training Grant","award":["5T32 HL007062-42"],"award-info":[{"award-number":["5T32 HL007062-42"]}]},{"name":"American Cancer Society, Clinical Scientist Development Grant","award":["CSDG-18-139-01-CSM"],"award-info":[{"award-number":["CSDG-18-139-01-CSM"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.leukres.2020.106404","type":"journal-article","created":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T13:00:14Z","timestamp":1591880414000},"page":"106404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Evolution of clonal dynamics and differential response to targeted therapy in a case of systemic mastocytosis with associated myelodysplastic syndrome"],"prefix":"10.1016","volume":"95","author":[{"given":"Hyun Don","family":"Yun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Lue","family":"Antony","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Linden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klara E.","family":"Noble-Orcutt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2834-0421","authenticated-orcid":false,"given":"Craig E.","family":"Eckfeldt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6896-6213","authenticated-orcid":false,"given":"Celalettin","family":"Ustun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew C.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9386-4163","authenticated-orcid":false,"given":"Zohar","family":"Sachs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.leukres.2020.106404_bib0005","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3324\/haematol.2016.146563","article-title":"Advanced systemic mastocytosis: from molecular and genetic progress to clinical practice","volume":"101","author":"Ustun","year":"2016","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.leukres.2020.106404_bib0010","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/leu.2015.284","article-title":"Additional mutations in SRSF2, ASXL1 and\/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosis","volume":"30","author":"Jawhar","year":"2016","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.leukres.2020.106404_bib0015","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/leu.2015.4","article-title":"Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event","volume":"29","author":"Jawhar","year":"2015","journal-title":"Leukemia"},{"issue":"18","key":"10.1016\/j.leukres.2020.106404_bib0020","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1182\/blood-2018-02-833582","article-title":"CD44 is a RAS\/STAT5-regulated invasion receptor that triggers disease expansion in advanced mastocytosis","volume":"132","author":"Mueller","year":"2018","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.leukres.2020.106404_bib0025","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1182\/blood-2016-09-731893","article-title":"Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts","volume":"129","author":"Valent","year":"2017","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.leukres.2020.106404_bib0030","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1182\/blood-2014-06-582809","article-title":"TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients","volume":"124","author":"Bejar","year":"2014","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.leukres.2020.106404_bib0035","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/cyto.a.22075","article-title":"Single-cell mass cytometry adapted to measurements of the cell cycle","volume":"81","author":"Behbehani","year":"2012","journal-title":"Cytometry A"},{"issue":"2","key":"10.1016\/j.leukres.2020.106404_bib0040","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/leu.2013.192","article-title":"STAT transcription factors in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention","volume":"28","author":"Dorritie","year":"2014","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.leukres.2020.106404_bib0045","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1038\/leu.2016.377","article-title":"Mass cytometry analysis reveals hyperactive NF Kappa B signaling in myelofibrosis and secondary acute myeloid leukemia","volume":"31","author":"Fisher","year":"2017","journal-title":"Leukemia"},{"issue":"5973","key":"10.1016\/j.leukres.2020.106404_bib0050","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1186624","article-title":"The Wnt\/beta-catenin pathway is required for the development of leukemia stem cells in AML","volume":"327","author":"Wang","year":"2010","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.leukres.2020.106404_bib0055","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2141.2010.08381.x","article-title":"ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia","volume":"151","author":"Gelsi-Boyer","year":"2010","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.leukres.2020.106404_bib0060","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/leu.2009.37","article-title":"Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates","volume":"23","author":"Tefferi","year":"2009","journal-title":"Leukemia"},{"issue":"26","key":"10.1016\/j.leukres.2020.106404_bib0065","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1056\/NEJMoa1513098","article-title":"Efficacy and safety of midostaurin in advanced systemic mastocytosis","volume":"374","author":"Gotlib","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.leukres.2020.106404_bib0070","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.3324\/haematol.2015.136002","article-title":"Stat5 is critical for the development and maintenance of myeloproliferative neoplasm initiated by Nf1 deficiency","volume":"101","author":"Sachs","year":"2016","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.leukres.2020.106404_bib0075","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00277-009-0835-2","article-title":"Cell cycle and apoptosis regulatory gene expression in the bone marrow of patients with de novo myelodysplastic syndromes (MDS)","volume":"89","author":"Economopoulou","year":"2010","journal-title":"Ann. Hematol."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212620301090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212620301090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:00:38Z","timestamp":1758934838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212620301090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":15,"alternative-id":["S0145212620301090"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2020.106404","relation":{},"ISSN":["0145-2126"],"issn-type":[{"type":"print","value":"0145-2126"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolution of clonal dynamics and differential response to targeted therapy in a case of systemic mastocytosis with associated myelodysplastic syndrome","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2020.106404","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106404"}}